{"name":"Y Biologics Inc.","slug":"y-biologics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE0wX1Rzb0hHa09uM0JINUJuYUtyZjhDWnUxendKREkxQkRRM3Zwc0NXRnN0N0ZfUHRoSDd1Rl9nUkV6cnBPMFZadTlacUxyUDlHU3ZCQUE1YnFOeEwzYlJRZzFRSUVCMTg?oc=5","date":"2026-04-04","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxNZUhpN2RrRU5EMnNIblJLU2s0Y3FSbjduWFJvN0NjeDdFLURoOGJnSWstLWxPa202ekduS1ZLRlB4akkwbUx5MUlocV9MMF9zRHdlUml0Y1VWcThBblYwbFg3M1FhRkdIakFFSHIxUGwwZGo1aGR3SVJ2cjBHeVI0S0ZjVHVBYndzbHR6UGF6OWpUaGpDeEdWc3RfUDA1TGktQ2hwZmVlWnRLbnNsMGE0SmdGTjBaSEMyY3JoRmtuamJ4X0FZSmJTQjkzNnZIT0VVRU9wVWo1ZUhoZkJuQmdVVEJQWEpnSVFJNEVBazUxWERnQQ?oc=5","date":"2026-03-27","type":"pipeline","source":"Barchart.com","summary":"TIGIT Inhibitor Clinical Pipeline Strengthens as 14+ Companies Advance 18+ Novel Immunotherapy Candidates | DelveInsight - Barchart.com","headline":"TIGIT Inhibitor Clinical Pipeline Strengthens as 14+ Companies Advance 18+ Novel Immunotherapy Candidates | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-12","type":"pipeline","source":"GlobeNewswire","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements - GlobeNewswire","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNMlVMWlBQTmZ4SzQ4TnNIQnVQQjI2QmJXblNuWnZxVndTekhGR0xWc2VaWFFoRFNhbm5MdTluTGFHcWFlUUxWMGdnS01TMmdfWW50SkNVUkcyNGZJcTZ0M2NPbkVUWWdkRjZWOXFWcy1lMnpUdUpPVDZKbkw3MVNrQllxaDg2cjRQM0N0NjFpM0d0YXMwQ1E0?oc=5","date":"2026-02-26","type":"earnings","source":"finviz.com","summary":"Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues - finviz.com","headline":"Mirum's Q4 Earnings Lag, Higher Product Sales Drive Y/Y Revenues","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxPWDhRelFoNmVVZzhKODB2M3g4bmdIeVVkSDJYZUhIbHlkZVlSdUtlWjJ1dFJDRDlWR3lueWdFQkstYlVlUW5BOWdkVzhaVlJqY2JTVEhRNzhucmJMam1yZFVkdVpEazEwUm0td0drYnBOLTVWQVZwYlUxYlZST0RaNjBwY2ZrZFh2OTI0dm5HY2Zoa0I2VzhNNE54aGdBTnZ5SVVBWWlwbWRRaGpoYmFVXzNvcm84RmNRTUFGaG5CNHQyV2YwXzV1SHYxUmtBTUl5STVMNU00MmIxUEloZW9ITWtaOU5JRUVjSlhRMXBOMnNwWFpiUHBPTkdWNjMzY2RoQ3ZGeksxMUY?oc=5","date":"2026-01-13","type":"pipeline","source":"prnewswire.com","summary":"Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Program - prnewswire.com","headline":"Rakuten Medical and LOTTE Biologics Sign Manufacturing Agreement to Support Biopharmaceuticals in Global Oncology Progra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE5Cc09EVnhsTlo2a2hWUS04aEhWYmlQbUtZQjNtcEgxRUJZZG1ldXpicUlhbzVvWHhfd2lfZGxwRnZTSE9weE1PNjQ0LW5kYm0xaWREaVdTM29RbEJDb2ZDQVhfdzFIY0hGek5xaWhBeENFQzFqcENF?oc=5","date":"2025-08-26","type":"pipeline","source":"labiotech.eu","summary":"5 South Korean biotech companies making global waves - labiotech.eu","headline":"5 South Korean biotech companies making global waves","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPY1FTVVYtdF9vYnZ4VHF1WUFSaDA1M2tGMGNmNlYwbG5yS2lVMFFNclZRS3N0WXBTQS1YLVZLWlVFUHc0R01YTEVQQWJPRFE1Y3ZycWhuSm1IZ21VRHVYRTJITlZmeVpiREJveHk5QVcybHBUYy14UjU1ZUt5SHllYTdVWVQyRUxxTkFrNl9wQk81ekhleXk3MjFR?oc=5","date":"2025-08-05","type":"pipeline","source":"Fierce Pharma","summary":"Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100% - Fierce Pharma","headline":"Y-mAbs signs off on $412M sale to SERB Pharmaceuticals, sending shares up 100%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPVlo0UlJ3YmZfN1Foa3J1end3NHMyb0hXekVqQ0h3X2l6SVFwcnZlQkdGNXhqZzFGZWMwTUxxZkU5QTBZcUNGNDRheUIxWWVkMkZySm9qMXU0bnVadmVaMGRHdEF6RjU3SDJWM0VqNWQyaUJlUkNWY3puLUNIb1pSbk1HZEtBZFNkdmlkN1EzTmM4bjFkNkFpRHc0NjlZRnpWMDE1VGhkUzg?oc=5","date":"2025-06-17","type":"deal","source":"BioWorld News","summary":"Korea biotech roundup: four financings, six R&D deals mid-June - BioWorld News","headline":"Korea biotech roundup: four financings, six R&D deals mid-June","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOSkdFSkhPSkFPRWVFYnVhLUJaN3JrX0VUajdXU2ctcVdnd3VIWlRjUnN1MTZhSzQ5RzN5ZkxrZ1AwaEI3RWt5VHBiMUlOQUJQVGw5bnJfLTNxcDlTSDVFcjAtVW9PemNHTDdUR1N6VVRnZmJVZ0hWdWRfeVBJU1h1NFF6TndvQnM?oc=5","date":"2025-06-10","type":"patent","source":"Generics and Biosimilars Initiative","summary":"Samsung Biologics to spin-off Samsung Bioepis - Generics and Biosimilars Initiative","headline":"Samsung Biologics to spin-off Samsung Bioepis","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPVGhudTlQdmVrczBXOEY2Z3pDTmNKSWhVNXZvM3Jka1Y3VkhKMFdZYzIyaE9fb240SklNeVhWWWppRFhERWNOZ0FSQ2d6eU9zc2JaWmdqMWdkc1Nub1pXOHk5dkpGNk1kcXJkbjJBVzZGS041dkg1ODJsYUxCOGE2bkMzMzF2RUgyTlFsZXQtOFU2VFdPenk4dzBYQ0FoVl9wWnhMT1RZSm8zZw?oc=5","date":"2025-06-10","type":"deal","source":"BioWorld News","summary":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock - BioWorld News","headline":"Ligachem inks two mystery ADC deals with CSPC subsidiary Novarock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1xTGYzVWtVVTNBR3hkVEgyTUE5QXhiUFNkRk10UXJPaFA0eHBWTXp5TlducV9hNTdILUVyYzd6VWNKUWlLQ3lGNUUtMW9JQkVxYUFYTjBTX2hPcFVnQl9tcjByWVRtSGhBM2w2Q1B30gFyQVVfeXFMTnVucTh2R3dwVWxVRGRBSTd4QTlTbTFjeVVlM184VHJNSURWT016eHpwOVdWNERqNUpXZnprSjQyU3g3cnZVNGpqLWMweUVFVE12V01VNGJfU2xvdDhWOGxlMXBhUHJGYTNmcDY3cmJCNy1B?oc=5","date":"2025-04-30","type":"pipeline","source":"koreabiomed.com","summary":"Ubix Therapeutics accelerates TPD development with BTK target, eyes IPO in 2025 - koreabiomed.com","headline":"Ubix Therapeutics accelerates TPD development with BTK target, eyes IPO in 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE44VWpKanpONHZmSGlHWW1VZF95UFVtYnFuMFgwN3BrbmlVRFA0YXNYeGlfV2hpeHV2TFZKa0hXY29jVnJ2ekl1REcyZmRTT2lwQW1PYmhfRXREbk1lbW5vcG9GNU1uc0FIbXNDU0pn?oc=5","date":"2023-11-28","type":"pipeline","source":"KED Global","summary":"Samsung Biologics reaches record-breaking annual orders - KED Global","headline":"Samsung Biologics reaches record-breaking annual orders","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}